We understand that our clients are concerned if customs and trading arrangements between UK and EU change following the UK’s exit from EU on 31st October 2019.  Our clients can rest assured that maintaining a safe and effective medicines supply service to our patients will remain our primary focus.

Speeds Healthcare’s Chief Operating Officer and Operations Director, appointed with responsibility for procurement, have been working proactively for many months to mitigate risks in supply of medicines to our clients; these actions cover a multitude of measures.

If you’d like a response from us on your particular situation, then please contact our Business Development Director at peter.bradshawe@speedshealthcare.co.uk who will contact you with details relevant to you.